Champions Oncology Inc Stock Ownership - Who owns Champions Oncology?

Insider buying vs selling

Have Champions Oncology Inc insiders been buying or selling?
Daniel Newman MendelsonDirector2023-09-265,000$5.65
Daniel Newman MendelsonDirector2023-09-223,812$5.50
Daniel Newman MendelsonDirector2023-09-215,000$5.51
Daniel Newman MendelsonDirector2023-09-204,018$5.51
Daniel Newman MendelsonDirector2023-09-195,000$5.28
Ronnie MorrisCEO2023-03-1712,382$4.04
Joel AckermanDirector2022-10-1916,667$3.21
Philip P. BreitfeldDirector2022-10-128,333$3.21
Philip P. BreitfeldDirector2022-10-123,562$7.51
David SidranskyDirector2022-10-123,562$7.51

1 of 2

CSBR insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CSBR insiders and whales buy or sell their stock.

CSBR Shareholders

What type of owners hold Champions Oncology Inc stock?
Michael Maurice Brown173.92%23,442,589$142.53MInsider
David M. Mott139.10%18,750,000$114.00MInsider
Anthony A. Florence Jr.139.10%18,750,000$114.00MInsider
Forest Baskett139.10%18,750,000$114.00MInsider
Patrick J. Kerins139.10%18,750,000$114.00MInsider
M. James Barrett139.10%18,750,000$114.00MInsider
Peter J. Barris139.10%18,750,000$114.00MInsider
Scott D. Sandell139.10%18,750,000$114.00MInsider
Krishna Kittu Kolluri139.10%18,750,000$114.00MInsider
Peter W. Sonsini139.10%18,750,000$114.00MInsider

1 of 3

CSBR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CSBR1.96%98.04%Net BuyingNet Buying
FGEN77.12%12.50%Net SellingNet Selling
CDTX29.09%15.62%Net BuyingNet Buying
CMRX44.13%31.83%Net BuyingNet Buying

Champions Oncology Stock Ownership FAQ

Who owns Champions Oncology?

Champions Oncology (NASDAQ: CSBR) is owned by 43.11% institutional shareholders, 2,150.87% Champions Oncology insiders, and 0.00% retail investors. Michael Maurice Brown is the largest individual Champions Oncology shareholder, owning 23.44M shares representing 173.92% of the company. Michael Maurice Brown's Champions Oncology shares are currently valued at $145.58M.

If you're new to stock investing, here's how to buy Champions Oncology stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.